Pharmacological activity of Kaempferia parviflora extract against human bile duct cancer cell lines

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 4, 2009, Pages 695-698

  Leardkamolkarn, Vijittra ^a   Tiamyuyen, Sunida ^b   Sripanidkulchai, Bung orn ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Khon Kaen University ^*  (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Anti invasion; Anti proliferation; Apoptosis; Cholangiocarcinoma cell lines; KP.8.10

Indexed keywords

EID: 77951140167     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ashkenazi A, Dixit VM (1998). Death receptors: signaling and modulation. Science, 281, 1305-8.
2. Bors W, Saran M (1987). Radical scavenging by flavonoid antioxidants. Free Radic Res Commun, 2, 289-94.
3. Chou CC, Pan SL, Teng CM, Guh JH (2003). Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cells. Eur J Pharm Sci, 19, 403-12.
4. Fotsis T, Pepper MS, Aktas E, et al (1997). Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res, 57, 2916-21.
5. Garbett EA, Reed MW, Brown NJ (1999). Proteolysis in colorectal cancer. Mol Pathol, 52, 140-5.
6. Huang YT, Hwang JJ, Lee PP, et al (1999). Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol, 128, 999-1010.
7. Imai Y, Kubota Y, Yamamoto S, et al (2005). Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: an in vitro study. J Gastroenterol Hepatol, 20, 287-93.
8. Kelly T, Borset M, Abe E, Gaddy-Kurten D, Sanderson RD (2000). Matrix metalloproteinases in multiple myeloma. Leuk Lymphoma, 37, 273-81.
9. Khan SA, Taylor-Robinson SD, Toledano MB, et al (2002). Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol, 37, 806-813.
10. Ko CH, Shen SC, Lee TJ, Chen YC (2005). Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther, 4, 281-290.
11. Kubo S, Kinoshita H, Hirohashi K, Hamba H (1995). Hepatolithiasis associated with cholangiocarcinoma. World J Surg, 19, 637-641.
12. Kuo PL, Hsu YL, Kuo YC, Chang CH, Lin CC (2005). The anti-proliferative inhibition of ellipticine in human breast mda-mb-231 cancer cells is through cell cycle arrest and apoptosis induction. Anticancer Drugs, 16, 789-795.
13. Kuo YC, Kuo PL, Hsu YL, Cho CY, Lin CC (2006). Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells. Life Sci, 78, 2550-7.
14. Li LY, Luo X, Wang X (2001). Endonuclease G is an apoptotic DNase when released from mitochondria. Nature, 412, 95- 9.
15. Lindenmeyer F, Li H, Menashi S, Soria C, Lu H (2001). Apigenin acts on the tumor cell invasion process and regulates protease production. Nutr Cancer, 39, 139-147.
16. Okuda K, Nakanuma Y, Miyazaki M (2002). Cholangio-carcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepato, l17, 1049-55.
17. Panthong A, Tassaneeyakul W, Kanjanapothi D, Tantiwachwuttikul P, Reutrakul V (1989). Anti-inflammatory activity of 5,7-dimethoxyflavone. Planta Med, 55, 133-6.
18. Patanasethanont D, Nagai J, Matsuura C, et al (2007a). Modulation of function of multidrug resistance associated- proteins by Kaempferia parviflora extracts and their components. Eur J Pharmacol, 566, 67-74.
19. Patanasethanont D, Nagai J, Yumoto R, et al (2007b). Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function. J Pharm Sci, 96, 223-33.
20. Patel T (2001). Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology, 33, 1353-7.
21. Pongchairerk U, Guan JL, Leardkamolkarn V (2005). Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1. World J Gastroenterol, 11, 5845-52.
22. Rattanasinganchan P, Leelawat K, Treepongkaruna SA, et al (2006). Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient. World J Gastroenterol, 12, 6500-6506.
23. Robak J, Gryglewski RJ (1988). Flavonoids are scavengers of superoxide anions. Biochem Pharmacol, 37, 837-841.
24. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA (2005). Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology, 128, 620-6.
25. Sirisinha S, Tengchaisri T, Boonpucknavig S, et al (1991). Establishment and characterization of a cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer. Asian Pac J Allergy Immunol, 9, 153-7.
26. Slee EA, Harte MT, Kluck RM, et al (1999). Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol, 144, 281-92.
27. Susin SA, Lorenzo HK, Zamzami N, et al (1999). Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397, 441-6.
28. Sutthanut K, Sripanidkulchai B, Yenjai C, Jay M (2007). Simultaneous identification and quantitation of 11 flavonoid constituents in Kaempferia parviflora by gas chromatography. J Chromatogr A, 1143, 227-33.
29. Takahashi M, Saito H, Okuyama T, et al (1999). Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody- mediated apoptosis. J Hepatol, 31, 315-22.
30. Taylor-Robinson SD, Toledano MB, Arora S, et al (2001). Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut, 48, 816-20.
31. Thomas GT, Lewis MP, Speight PM (1999). Matrix metalloproteinases and oral cancer. Oral Oncol, 35, 227- 33.
32. Upadhyay J, Shekarriz B, Nemeth JA, et al (1999). Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin Cancer Res, 5, 4105-10.
33. Wajant H (2003). Death receptors. Essays Biochem, 39, 53-71.
34. Wang IK, Lin-Shiau SY, Lin JK. (1999). Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer, 35, 1517-25.
35. Watanapa P, Watanapa WB (2002). Liver fluke-associated cholangiocarcinoma. Br J Surg, 89, 962-70.
36. Yenjai C, Prasanphen K, Daodee S, Wongpanich V, Kittakoop P (2004). Bioactive flavonoids from Kaempferia parviflora. Fitoterapia, 75, 89-92.